GHTC reflects on the recent midterm elections in the United States and implications for global health research and development.
Breakthroughs Blog: Congress
President signs spending bill that includes key boosts to global health research but no emergency funds for COVID-19
Months of tense congressional negotiations stretching nearly six months over schedule finally concluded with the signing of an omnibus spending package for fiscal year 2022. GHTC breaks down what that means for global health research.
As 2022 begins, GHTC is taking stock of the top global health R&D policy issues for the year ahead. Here are the top six topics GHTC will be tracking.
2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.